1st Quarter - Amendment

THE PERSONAL CARE PRODUCTS COUNCIL for PERSONAL CARE PRODUCTS COUNCIL

Firm
Client
Income
—
Expenses
$320,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2023 $470,000 Replaced
1st Quarter - Amendment (this page) Jul 19, 2023 $320,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Consumer Issues/Safety/Products CSP

Issues related to the safety of cosmetics, counterfeit products, PFAS ban; FDA sunscreen regulation Modernization of Cosmetics Regulation Act of 2022 (MoCRA) implementation

LobbyistCovered position, as disclosed
ELISE BAILEY New —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

H.R. 45 and S. 45, Small Business Tax Fairness and Compliance Simplification Act

LobbyistCovered position, as disclosed
ELISE BAILEY New —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 45 (118th), H.R. 45 (118th)

Labor Issues/Antitrust/Workplace LBR

Creating a Respectful and Open World for Natural (CROWN) Hair Act

LobbyistCovered position, as disclosed
ELISE BAILEY New —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Animals ANI

Humane Cosmetics Act

LobbyistCovered position, as disclosed
ELISE BAILEY New —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

China Regulatory Cosmetic Hygiene Supervision Regulations; Indonesia Halal Law; China trade policy related to tariff concerns; United States Innovation and Competition Act

LobbyistCovered position, as disclosed
ELISE BAILEY New —
NATALIE OBERMANN —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Budget/Appropriations BUD

FDA appropriations

LobbyistCovered position, as disclosed
ELISE BAILEY New —
KARIN ROSS —
MALLIKA VASTARE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.